158 related articles for article (PubMed ID: 1356013)
1. Somatostatin receptor imaging in the diagnosis and treatment of neuroendocrine tumors.
Lamberts SW; Reubi JC; Krenning EP
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):185-8. PubMed ID: 1356013
[TBL] [Abstract][Full Text] [Related]
2. Validation of somatostatin receptor scintigraphy in the localization of neuroendocrine tumors.
Lamberts SW; Reubi JC; Krenning EP
Acta Oncol; 1993; 32(2):167-70. PubMed ID: 8391830
[TBL] [Abstract][Full Text] [Related]
3. The visualization of gastroenteropancreatic endocrine tumors.
Lamberts SW; Chayvialle JA; Krenning EP
Metabolism; 1992 Sep; 41(9 Suppl 2):111-5. PubMed ID: 1355584
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptor imaging of endocrine gastrointestinal tumors.
Krenning EP; Kwekkeboom DJ; Oei HY; Reubi JC; van Hagen PM; Kooij PP; Reijs AE; Lamberts SW
Schweiz Med Wochenschr; 1992 Apr; 122(17):634-7. PubMed ID: 1350377
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptor imaging in vivo localization of tumors with a radiolabeled somatostatin analog.
Lamberts SW; Bakker WH; Reubi JC; Krenning EP
J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1079-82. PubMed ID: 1981011
[TBL] [Abstract][Full Text] [Related]
6. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin receptors: clinical implications for endocrinology and oncology.
Lamberts SW; de Herder WW; van Koetsveld PM; Koper JW; van der Lely AJ; Visser-Wisselaar HA; Hofland LJ
Ciba Found Symp; 1995; 190():222-36; discussion 236-9. PubMed ID: 7587649
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptor imaging with 123I-Tyr3-Octreotide.
Lamberts SW; Reubi JC; Bakker WH; Krenning EP
Z Gastroenterol; 1990 Sep; 28 Suppl 2():20-1. PubMed ID: 1980773
[TBL] [Abstract][Full Text] [Related]
9. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.
Reubi JC; Kvols LK; Waser B; Nagorney DM; Heitz PU; Charboneau JW; Reading CC; Moertel C
Cancer Res; 1990 Sep; 50(18):5969-77. PubMed ID: 2168286
[TBL] [Abstract][Full Text] [Related]
10. Octreotide scintigraphy localizes somatostatin receptor-positive islet cell carcinomas.
Becker W; Marienhagen J; Scheubel R; Saptogino A; Bakker WH; Breeman WA; Wolf F
Eur J Nucl Med; 1991; 18(11):924-7. PubMed ID: 1684323
[TBL] [Abstract][Full Text] [Related]
11. In vitro detection of somatostatin receptors in human tumors.
Reubi JC; Krenning E; Lamberts SW; Kvols L
Metabolism; 1992 Sep; 41(9 Suppl 2):104-10. PubMed ID: 1355582
[TBL] [Abstract][Full Text] [Related]
12. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy.
Lamberts SW; Hofland LJ; van Koetsveld PM; Reubi JC; Bruining HA; Bakker WH; Krenning EP
J Clin Endocrinol Metab; 1990 Sep; 71(3):566-74. PubMed ID: 2168430
[TBL] [Abstract][Full Text] [Related]
13. The visualization of gastroenteropancreatic endocrine tumors.
Lamberts SW; Chayvialle JA; Krenning EP
Digestion; 1993; 54 Suppl 1():92-7. PubMed ID: 8395433
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin-receptor imaging in the localization of endocrine tumors.
Lamberts SW; Bakker WH; Reubi JC; Krenning EP
N Engl J Med; 1990 Nov; 323(18):1246-9. PubMed ID: 2170840
[TBL] [Abstract][Full Text] [Related]
15. Indium-111-pentetreotide uptake in endocrine tumors and lymphoma.
Leners N; Jamar F; Fiasse R; Ferrant A; Pauwels S
J Nucl Med; 1996 Jun; 37(6):916-22. PubMed ID: 8683311
[TBL] [Abstract][Full Text] [Related]
16. Use of isotope-labeled somatostatin analogs for visualization of islet cell tumors.
van Eyck CH; Bruining HA; Reubi JC; Bakker WH; Oei HY; Krenning EP; Lamberts SW
World J Surg; 1993; 17(4):444-7. PubMed ID: 8395748
[TBL] [Abstract][Full Text] [Related]
17. 111In-octreotide scintigraphy in oncology.
Krenning EP; Kwekkeboom DJ; Reubi JC; Van Hagen PM; van Eijck CH; Oei HY; Lamberts SW
Metabolism; 1992 Sep; 41(9 Suppl 2):83-6. PubMed ID: 1355591
[TBL] [Abstract][Full Text] [Related]
18. Treatment with Sandostatin and in vivo localization of tumors with radiolabeled somatostatin analogs.
Lamberts SW; Bakker WH; Reubi JC; Krenning EP
Metabolism; 1990 Sep; 39(9 Suppl 2):152-5. PubMed ID: 2169572
[TBL] [Abstract][Full Text] [Related]
19. The clinical use of somatostatin analogues in the treatment of cancer.
Lamberts SW; Krenning EP; Klijn JG; Reubi JC
Baillieres Clin Endocrinol Metab; 1990 Mar; 4(1):29-49. PubMed ID: 1975166
[TBL] [Abstract][Full Text] [Related]
20. Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
Virgolini I; Traub T; Novotny C; Leimer M; Füger B; Li SR; Patri P; Pangerl T; Angelberger P; Raderer M; Burggasser G; Andreae F; Kurtaran A; Dudczak R
Curr Pharm Des; 2002; 8(20):1781-807. PubMed ID: 12171531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
